CMFRI to commercialise two seaweed-based nutraceuticals The Fishsite dated 20th December 2023

CMFRI, Library (2023) CMFRI to commercialise two seaweed-based nutraceuticals The Fishsite dated 20th December 2023. The Fishsite.

Text The Fishsite_20-12-2023.pdf Download (338kB)

Abstract

The Central Marine Fisheries Research Institute (CMFRI) has commercialised the patent-protected technologies of two seaweed-based nutraceutical products -one to boost anti-viral immunity and the other to combat high cholesterol or dyslipidemia. The products are expected to reach the market within six months from Pioneer Pharmaceuticals. Dr A. Gopalakrishnan, Director of the institute, had signed a licence agreement with Joby George, Managing Partner, Pioneer Pharmaceuticals Limited, a wellness and pharmaceutical company based in Kochi, for commercial production and marketing of the products.

Actions (login required)

View Item